STAT Madness Is on, and Gladstone Is a Finalist
STAT Madness Is on, and Gladstone Is a Finalist
A Gladstone discovery could be selected as the top innovation in biomedicine
Awards COVID-19 Doudna Lab Krogan Lab Ott Lab CRISPR/Gene EditingGladstone NOW: The Campaign Join Us on the Journey ✕
16 - 30 of 70 Results Clear All
A Gladstone discovery could be selected as the top innovation in biomedicine
Awards COVID-19 Doudna Lab Krogan Lab Ott Lab CRISPR/Gene EditingA team of Gladstone and UCSF scientists used a large-scale genetic approach to map the structure of protein complexes in live cells
News Release Research (Publication) Data Science and Biotechnology Krogan Lab Protein InteractionThe new study points toward ways to treat not only COVID-19, but future coronaviruses that might emerge
News Release Research (Publication) COVID-19 Virology Krogan Lab Ott LabLife Science—The online science news hub Life Sciences highlights recent work from Senior Investigators Melanie Ott, MD, PhD, and Nevan Krogan, PhD, and their colleagues at BioHub and Synthego Corporation. The work describes the identification of host factors common to three coronaviruses including SARS-CoV-2, and could help bootstrap efforts to stem current and future coronavirus epidemics.
Gladstone Experts COVID-19 Data Science and Biotechnology Virology Krogan Lab Ott Lab CRISPR/Gene EditingMedium—Senior Investigator Nevan Krogan, PhD, explains his group’s recent discovery of the cellular processes the coronavirus commandeers to grow and propagate and how this information can be harnessed for drug development.
Gladstone Experts COVID-19 Data Science and Biotechnology Krogan LabSan Francisco Chronicle—Commenting on the disappointing recent reports about antibodies as barriers against coronavirus infection, Senior Investigator Nevan Krogan, PhD, and Visiting Scientist Danielle Swaney, PhD, emphasize the need for drug treatments as an alternative, and describe how they look for such treatments.
Gladstone Experts COVID-19 Data Science and Biotechnology Krogan Labconsiderable.—Senior Investigator Nevan Krogan, PhD, recounts his team’s recent finding that drugs that target enzymes known as kinases, many of which were developed to fight cancer, could be effective against COVID-19.
Gladstone Experts COVID-19 Data Science and Biotechnology Krogan LabFinding reveals achilles’ heel easily targeted with existing drugs
COVID-19 Virology Krogan LabMilwaukee Journal Sentinel—Senior Investigator Nevan Krogan, PhD, explains his team’s latest discovery that drugs belonging to a class known as kinase inhibitors can slow SARS-CoV-2 proliferation in cultured cells more efficiently than the antiviral Remdesivir.
Gladstone Experts COVID-19 Data Science and Biotechnology Krogan LabScreening potential COVID-19 drug therapies through lung organoids promises a faster pipeline to approved treatments.
Gladstone Experts COVID-19 Virology Krogan Lab Ott Lab OrganoidsKCBS—Gladstone Senior Investigator Nevan Krogan spoke to KCBS radio about his team’s efforts to find therapies for COVID-19.
Gladstone Experts COVID-19 Data Science and Biotechnology Krogan LabNew York Academy of Sciences—New York Academy of Sciences: Many winners of the NYAS Blavatnik Award for Young Scientists have redirected their research efforts to focus on COVID-19. These include Gladstone Senior Investigators Leor Weinberger and Nevan Krogan.
Gladstone Experts COVID-19 Data Science and Biotechnology Virology Krogan Lab Weinberger LabMEAWW—Gladstone Investigator Nevan Krogan describes his efforts to identify drugs that affect COVID-19, including the finding that a component of cough syrup may have the undesirable effect of improving viral replication.
Gladstone Experts COVID-19 Data Science and Biotechnology Krogan LabSan Francisco Chronicle—Gladstone Senior Investigator Nevan Krogan describes his team’s rapid response to the COVID-19 pandemic, and how by mapping the interactions between SARS-CoV-2 and human cells they hope to identify ways to eliminate the deadly virus.
Gladstone Experts COVID-19 Data Science and Biotechnology Krogan LabNew York Times—Gladstone Investigator Nevan Krogan describes his team’s effort to identify drugs that target the human proteins that interact with SARS-CoV-2, and the hope that this effort may lead to effective therapies for COVID-19 that can move rapidly through the testing and approval process.
Gladstone Experts COVID-19 Data Science and Biotechnology Krogan Lab